NCT00076323已完成不适用
A New Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
Walter Reed Army Institute of Research (WRAIR)2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2003年12月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 14
- 试验地点
- 2
- 主要终点
- Difference in degree of hemolysis of G6PD(-) red blood cells in treated vs untreated matched samples.
研究概览
简要总结
This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Normal clinical evaluation
- •Willing and able to make all scheduled visits
排除标准
- •pregnant or planning pregnancy
- •Have taken any anti-malarial medication in past month
- •Positive blood tests for HIV and specific types of hepatitis
- •Allergic to primaquine
结局指标
主要结局
Difference in degree of hemolysis of G6PD(-) red blood cells in treated vs untreated matched samples.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver InjuryDrug Induced Liver InjuryNCT01000766University of North Carolina, Chapel Hill25
招募中
不适用
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of LiposarcomasAtypical Lipomatous TumorLiposarcomaNCT04224064Institut du Cancer de Montpellier - Val d'Aurelle158
终止
不适用
ThRombosis ExclUsion STudyDeep Venous ThrombosesPulmonary EmbolismVenous ThromboembolismNCT03477968Diagnostica Stago5,935
招募中
不适用
Evaluation of Two New Innovative Haemostasis Tests: Measurement of the Active Form of GTP-bound Rap1b (aRap1b) in Platelets and the Pro and Antithrombotic Balance of Circulating Endothelial Microvesicles (patEMV) (INNOV-CKD Test)Chronic Renal FailureNCT05765630Assistance Publique Hopitaux De Marseille115
进行中（未招募）
不适用
AML/MDS Drug Sensitization by in Vivo Chemotherapy AdministrationMyelodysplastic SyndromesAcute Myeloid LeukemiaNCT04263181Washington University School of Medicine80